Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study
NCT ID: NCT05101473
Last Updated: 2022-08-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
3 participants
INTERVENTIONAL
2021-09-01
2022-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The primary study hypothesis is that exercise therapy for people with an active diabetic foot ulcer will have high participant recruitment and adherence to treatment and that it does not affect wound healing negatively.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Passive Training as a Treatment for Diabetic Foot Ulcers
NCT02785198
On the Move: Center and Home-Based Exercise to Enhance Mobility in Diabetic Foot Ulcer Recovery
NCT06894563
Non-weight Bearing Exercise for Accelerated Healing of Diabetic Foot Ulcers
NCT05603273
Investigation of the Effects of Different Exercise on Wound Healing in Patients wıth Diabetic Foot Wounds
NCT05422846
Effectiveness of Buerger Allen Exercise Among Type 2 Diabetes Mellitus Patients With Foot Ulcer
NCT05747872
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
The trial will be reported with reference to the extended CONSORT guidelines.
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise therapy
Exercises will be performed with minimal weight bearing on foot soles, as recommended in the literature for people with diabetic peripheral neuropathy.
Exercise Therapy
The overall framework will consist of two supervised exercise sessions per week of 30-60 min duration for 12 weeks in order to be able to result in the physiological adaptions that are needed to improve the health of the individual participant.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise Therapy
The overall framework will consist of two supervised exercise sessions per week of 30-60 min duration for 12 weeks in order to be able to result in the physiological adaptions that are needed to improve the health of the individual participant.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetes mellitus
* Non-surgical ulcer located distal to the malleoli
* Willingness to participate in a 12-week supervised exercise therapy intervention twice a week
* Prescribed with a therapeutic shoe, orthopaedic specialist shoe from the outpatient clinic or a specialized podiatrist.
Exclusion Criteria
* People that are wheelchair-bound
* People with a prescribed cast or walker boot
* Unable to understand Danish.
* Diagnosed with or awaiting evaluation of suspected acute phase Charcot arthropathy or osteomyelitis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Holbaek Sygehus
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SUH Køge
Køge, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REG-075-2021
Identifier Type: OTHER
Identifier Source: secondary_id
SJ-928
Identifier Type: OTHER
Identifier Source: secondary_id
Exercise for DFU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.